Literature DB >> 14506623

Interactions of conjugated linoleic acid and lipoic acid on insulin action in the obese Zucker rat.

Mary K Teachey1, Zachary C Taylor, Thomas Maier, Vitoon Saengsirisuwan, Julie A Sloniger, Stephan Jacob, Martin J Klatt, Arne Ptock, Klaus Kraemer, Oliver Hasselwander, Erik J Henriksen.   

Abstract

The fatty acid conjugated linoleic acid (CLA) and the antioxidant R-(+)-alpha-lipoic acid (R-ALA) individually enhance glucose tolerance and insulin action on skeletal muscle glucose transport in the insulin-resistant obese Zucker rat. To date, no study has assessed the potential interactions between these 2 interventions in treating insulin resistance. The present study was designed to determine whether chronic treatment with CLA and R-ALA in combination would enhance skeletal muscle glucose transport to a greater extent than either intervention individually. CLA, R-ALA, or a combination treatment of R-ALA and CLA were administered to female obese Zucker rats for 20 days at low or high doses. Whereas low-dose R-ALA (10 mg/kg body weight) alone did not alter muscle glucose transport, low-dose CLA (0.3 g/kg) induced a significant increase (38%, P <.05) in insulin-mediated glucose transport in epitrochlearis, but not in soleus. Low-dose combination therapy brought about the greatest enhancement of insulin-mediated glucose transport in epitrochlearis (77%) and soleus (54%), with the latter effect being associated with a 50% reduction in protein carbonyls (an index of tissue oxidative stress) and a 33% diminution in muscle triglycerides. High-dose treatments with CLA (1.5 g/kg), R-ALA (50 mg/kg), and the combination of CLA and R-ALA elicited increases in insulin-mediated glucose transport in epitrochlearis (57%, 58%, and 77%) and soleus (32%, 35%, and 54%). However, whereas the individual high-dose treatments with CLA and R-ALA reduced protein carbonyls (63% and 49%) and triglycerides (29% and 28%) in soleus, no further reductions were observed with the high-dose combination treatment groups. These findings support a significant interaction between low doses of CLA and R-ALA for enhancement of insulin action on skeletal muscle glucose transport, possibly via reductions in muscle oxidative stress and in lipid storage.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14506623     DOI: 10.1016/s0026-0495(03)00145-8

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  8 in total

1.  Interactions of the advanced glycation end product inhibitor pyridoxamine and the antioxidant alpha-lipoic acid on insulin resistance in the obese Zucker rat.

Authors:  Elizabeth A Muellenbach; Cody J Diehl; Mary K Teachey; Katherine A Lindborg; Tara L Archuleta; Nicholas B Harrell; Gaby Andersen; Veronika Somoza; Oliver Hasselwander; Markus Matuschek; Erik J Henriksen
Journal:  Metabolism       Date:  2008-10       Impact factor: 8.694

Review 2.  Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus.

Authors:  Surapon Tangvarasittichai
Journal:  World J Diabetes       Date:  2015-04-15

3.  Effects of conjugated linoleic acid and troglitazone on lipid accumulation and composition in lean and Zucker diabetic fatty (fa/fa) rats.

Authors:  Angela A Wendel; Martha A Belury
Journal:  Lipids       Date:  2006-03       Impact factor: 1.880

4.  Critical role of the transient activation of p38 MAPK in the etiology of skeletal muscle insulin resistance induced by low-level in vitro oxidant stress.

Authors:  Maggie K Diamond-Stanic; Elizabeth M Marchionne; Mary K Teachey; David E Durazo; John S Kim; Erik J Henriksen
Journal:  Biochem Biophys Res Commun       Date:  2011-01-15       Impact factor: 3.575

5.  α-Lipoic acid reduced weight gain and improved the lipid profile in rats fed with high fat diet.

Authors:  Eun Young Seo; Ae Wha Ha; Woo Kyoung Kim
Journal:  Nutr Res Pract       Date:  2012-06-30       Impact factor: 1.926

6.  Effects of concurrent training on oxidative stress and insulin resistance in obese individuals.

Authors:  Niara da Silva Medeiros; Fabiana Guichard de Abreu; Alana Schraiber Colato; Leandro Silva de Lemos; Thiago Rozales Ramis; Gilson Pires Dorneles; Cláudia Funchal; Caroline Dani
Journal:  Oxid Med Cell Longev       Date:  2015-02-04       Impact factor: 6.543

7.  The prostacyclin analog beraprost sodium ameliorates characteristics of metabolic syndrome in obese Zucker (fatty) rats.

Authors:  Nahoko Sato; Masayuki Kaneko; Mitsutaka Tamura; Hajimu Kurumatani
Journal:  Diabetes       Date:  2010-01-12       Impact factor: 9.461

8.  The significance of routine biochemical markers in patients with major depressive disorder.

Authors:  You-Fan Peng; Yang Xiang; Ye-Sheng Wei
Journal:  Sci Rep       Date:  2016-09-29       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.